Apyx Medical Stock Buy Hold or Sell Recommendation
APYX Stock | USD 1.69 0.24 16.55% |
Given the investment horizon of 90 days and complete risk avoidance on your part, our recommendation regarding Apyx Medical is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Apyx Medical given historical horizon and risk tolerance towards Apyx Medical. When Macroaxis issues a 'buy' or 'sell' recommendation for Apyx Medical, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Apyx Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide. In addition, we conduct extensive research on individual companies such as Apyx and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Apyx |
Execute Apyx Medical Buy or Sell Advice
The Apyx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Apyx Medical. Macroaxis does not own or have any residual interests in Apyx Medical or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Apyx Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | OK | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Apyx Medical Trading Alerts and Improvement Suggestions
Apyx Medical is way too risky over 90 days horizon | |
Apyx Medical may become a speculative penny stock | |
Apyx Medical appears to be risky and price may revert if volatility continues | |
The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.85 M) with profit before overhead, payroll, taxes, and interest of 29.13 M. | |
Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
Roughly 16.0% of the company shares are held by company insiders | |
Latest headline from gurufocus.com: Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference |
Apyx Medical Returns Distribution Density
The distribution of Apyx Medical's historical returns is an attempt to chart the uncertainty of Apyx Medical's future price movements. The chart of the probability distribution of Apyx Medical daily returns describes the distribution of returns around its average expected value. We use Apyx Medical price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Apyx Medical returns is essential to provide solid investment advice for Apyx Medical.
Mean Return | 0.50 | Value At Risk | -6.45 | Potential Upside | 10.00 | Standard Deviation | 5.54 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Apyx Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Apyx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as Apyx Medical, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading Apyx Medical back and forth among themselves.
Shares | Rathbone Brothers Plc | 2024-06-30 | 251.3 K | Perkins Capital Management Inc | 2024-09-30 | 217.5 K | Renaissance Technologies Corp | 2024-09-30 | 203.3 K | Bridgeway Capital Management, Llc | 2024-09-30 | 140.4 K | Kestra Advisory Services, Llc | 2024-06-30 | 124.2 K | Caption Management, Llc | 2024-09-30 | 115.5 K | State Street Corp | 2024-06-30 | 109.3 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 108.3 K | Northern Trust Corp | 2024-09-30 | 103.4 K | Archon Capital Management Llc | 2024-06-30 | 3.1 M | Royce & Associates, Lp | 2024-09-30 | 2.6 M |
Apyx Medical Cash Flow Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change To Inventory | (2.4M) | 615K | (2.9M) | (5.6M) | 1.5M | 1.5M | |
Change In Cash | 42.2M | (16.9M) | (11.0M) | (20.7M) | 33.5M | 35.1M | |
Free Cash Flow | (19.8M) | (16.6M) | (11.2M) | (21.3M) | (5.8M) | (6.1M) | |
Depreciation | 754K | 887K | 903K | 890K | 692K | 726.5K | |
Other Non Cash Items | 215K | 996K | 603K | 628K | 2.3M | 2.4M | |
Capital Expenditures | 1.3M | 581K | 723K | 1.0M | 533K | 910.0K | |
Net Income | (19.7M) | (11.9M) | (15.2M) | (23.3M) | (18.9M) | (17.9M) | |
End Period Cash Flow | 58.8M | 41.9M | 30.9M | 10.2M | 43.7M | 45.8M | |
Change Receivables | (4.0M) | (558K) | (4.9M) | 1.9M | 1.7M | 1.8M | |
Net Borrowings | (60K) | (369K) | (238K) | (148K) | (170.2K) | (178.7K) | |
Change To Netincome | 3.7M | 5.2M | 5.6M | 7.1M | 6.4M | 6.7M | |
Investments | 61.8M | (581K) | (723K) | (1.0M) | 6.7M | 7.0M |
Apyx Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Apyx Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Apyx Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Apyx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | 0.75 | |
σ | Overall volatility | 5.67 | |
Ir | Information ratio | 0.07 |
Apyx Medical Volatility Alert
Apyx Medical shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Apyx Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Apyx Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Apyx Medical Fundamentals Vs Peers
Comparing Apyx Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Apyx Medical's direct or indirect competition across all of the common fundamentals between Apyx Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Apyx Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Apyx Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Apyx Medical to competition |
Fundamentals | Apyx Medical | Peer Average |
Return On Equity | -1.1 | -0.31 |
Return On Asset | -0.22 | -0.14 |
Profit Margin | (0.58) % | (1.27) % |
Operating Margin | (0.46) % | (5.51) % |
Current Valuation | 74.45 M | 16.62 B |
Shares Outstanding | 37.64 M | 571.82 M |
Shares Owned By Insiders | 16.18 % | 10.09 % |
Shares Owned By Institutions | 40.43 % | 39.21 % |
Number Of Shares Shorted | 140.48 K | 4.71 M |
Price To Earning | 4.04 X | 28.72 X |
Price To Book | 5.76 X | 9.51 X |
Price To Sales | 1.30 X | 11.42 X |
Revenue | 52.35 M | 9.43 B |
Gross Profit | 29.13 M | 27.38 B |
EBITDA | (18.11 M) | 3.9 B |
Net Income | (18.85 M) | 570.98 M |
Cash And Equivalents | 20.06 M | 2.7 B |
Cash Per Share | 0.58 X | 5.01 X |
Total Debt | 38.5 M | 5.32 B |
Debt To Equity | 0.02 % | 48.70 % |
Current Ratio | 4.45 X | 2.16 X |
Book Value Per Share | 0.77 X | 1.93 K |
Cash Flow From Operations | (5.25 M) | 971.22 M |
Short Ratio | 5.49 X | 4.00 X |
Earnings Per Share | (0.82) X | 3.12 X |
Price To Earnings To Growth | (0.58) X | 4.89 X |
Target Price | 2.83 | |
Number Of Employees | 252 | 18.84 K |
Beta | 1.21 | -0.15 |
Market Capitalization | 63.62 M | 19.03 B |
Total Asset | 79.24 M | 29.47 B |
Retained Earnings | (54.45 M) | 9.33 B |
Working Capital | 57.62 M | 1.48 B |
Note: Acquisition by Todd Hornsby of 15000 shares of Apyx Medical at 1.77 subject to Rule 16b-3 [view details]
Apyx Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Apyx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Apyx Medical Buy or Sell Advice
When is the right time to buy or sell Apyx Medical? Buying financial instruments such as Apyx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Apyx Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.